| ???? |
2'H- Androst -2- ?? [3,2-c] ?? ? -17- ?, 17- ??-, (5a, 17b) - |
| ?? |
2'H-5a-Androst-2-eno[3,2-c]???-17b-?, 17-??-(8CI); ??????[7,8]????[2,3-c]???-1-?,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-????????-1,10a,12a-????-(6CI,7CI); 17- ?? -5a- ??? ??? [3,2-c] ?? ? -17b- ?; 17- ?? - ?? ?? [4 ', 3': 2,3] -5a- androstan -17b- ?; 17a-??-17b-?????-5a-??????(3,2-c)???; 17b-?????-17-??-5a-??????[3,2-c]???; 17b-?????-17a-??-5a-??????[3,2-c]???; ???; ???????; ???????; ????????????; ????; NSC233046; Stanabolic; ??? ??; ?????; ????; ??????; ????; ?? 14833; ??????; ????; Winstrol ??; ???? ?? |
| ?? ?? |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-;2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol; 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol; 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole; 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC233046; Stanabolic; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V |
| ??? |
C21H32N2O |
| ??? |
328.55 |
| cas?? |
302-96-5 |
| ?? ?? |
![302-96-5 2'H- Androst -2- ?? [3,2-c] ?? ? -17- ?, 17- ??-, (5a, 17b) -](https://images-a.chemnet.com/suppliers/chembase/cas178/302-96-5.jpg)
|
| ?? |
1.129g/cm3 |
| ??? |
490.8°Cat760mmHg |
| ??? |
250.7°C |
| ??? ?? |
|
| ??? ?? |
|
| ?? ?? |
x." target="_blank">Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.:;
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
